Connect with us

Published

on

Apple CEO Tim Cook (L) takes a selfie with a greets customers on arrival for the release of the Vision Pro headset at the Apple Store in New York City on February 2, 2024. 

Angela Weiss | AFP | Getty Images

When Apple revealed the Vision Pro in 2023, it called the $3,500 headset its next “major platform.” Two years later, and a year after going on sale, the device is thin on apps. 

Apple doesn’t regularly release stats on the number of Vision Pro apps that are available, and it’s hard to tell how many new apps come out in any given month. According to consultancy AppFigures, which tracks Apple’s platforms, the number of new Vision Pro apps has declined every month since the device hit the market in February 2024.

When Apple unveiled the Vision Pro, executives said that developers would be able to create new experiences that weren’t possible with traditional computers. But so far, top developers remain mostly focused elsewhere, and major tech companies like Google, Meta and Netflix have yet to release their most important apps for the headset.

Many of the new apps and ideas for the Vision Pro are coming from independent developers, hacking on the weekends while holding down day jobs. 

One person in the indie camp is Adam Roszyk, a programmer in Poland who has created 17 Vision Pro apps since the headset was first released.

For $4, Roszyk’s Night Vision app lets a Vision Pro user tap the depth-sensing cameras of the device to see objects in the dark. If you spend $5, you can perform a chore in a Luigi’s Mansion-like video game using the app Vacuume, which overlays virtual coins on your floor that you can vacuum up, along with any real dirt or dust. And for $6, Roszyk’s app Scan Export lets users create a 3D digital scan of an entire building just by walking around, a useful tool for those in construction or real estate. 

“We are still early, and we don’t really know how it can be really useful in your life,” Roszyk said. “There’s so many different ideas that just come to your mind.”

Roszyk continues to work on Vision Pro apps because he said he believes “spatial computing” — Apple’s preferred terminology for headset and glasses technology that can integrate 3D objects with the world around them — will be the next big platform. Roszyk is betting that developing apps now can put him in prime position when more people are walking around with a Vision Pro or, perhaps some day, lightweight glasses. 

“This type of computing is the future,” Roszyk said. “I would definitely compare it to the first iPhones.”

Roszyk’s efforts have made him money, but not enough for Vision Pro development to become his full-time job. His 17 apps have cleared about $4,000 on the App Store in the last three months. That number is growing as he releases more apps and more people find out about them, Roszyk said. 

Apple updated its most recent Vision Pro app count in August, with CEO Tim Cook telling investors on an earnings call that the platform had 2,500 apps. That number covers fully immersive apps that overlay virtual objects over the real world as well as 2D apps with some spatial components.

By AppFigures’ count, less than 1,900 of these apps remained active at the end of January.

Apple declined to comment.

Apple Vision Pro launches in more markets outside the U.S.

Rival Meta in 2023 said that it had 500 apps in its Quest store, and the company last year said that number had multiplied by 10.

The Quest 3S, which has many of the same features as the Vision Pro, starts at $300. Meta also sold millions of its predecessors in recent years. While Meta hasn’t revealed how many users it has, its Meta Quest app was downloaded about 6 million times in 2024, according to AppFigures data, a useful proxy because users need to download the app in order to set up the headset.

There are also about 1.5 million Vision Pro apps that are ported versions of iPhone and iPad apps. Apple automatically ports iPhone and iPad apps to the Vision Pro when they’re uploaded, but companies can decline. Those apps can be used inside the headset but appear as 2D flat screens. Meta started to emulate that strategy last year with 2D Android apps for Quest, but the company doesn’t have the same library of millions of existing mobile apps.

Apple doesn’t publish Vision Pro sales, but one estimate from IDC suggests fewer than 1 million devices have been sold.

Some services like Netflix and YouTube, and game streaming services like Nvidia GeForce Now can be accessed through the Apple Vision Pro’s browser. And existing apps often receive updates that introduce a spatial mode, such as the NBA scores app, which recently got an experimental feature that allows users to watch a live basketball game as if the players were miniature figurines on a table.

Apple Arcade, a monthly game subscription from Apple, does require that its titles support the Vision Pro in addition to iPhones and iPads. Apple Arcade developers are paid by Apple and their apps are free to subscribers.

Although many of those games are 2D, some are exclusive to the Vision Pro. In January, Apple released Gears & Goo, a Vision Pro app that enables the player to control an army of goofy frog-like characters on a table in the real world.

Meanwhile, Meta is actively courting VR developers with a promise that they can make money. Meta in January said that its payment volume for Quest headsets rose by 12% last year, although it didn’t cite a total number. Meta has also said it has 200 apps that have made more than $1 million through software sales.

No iPhone-like app gold rush

The Apple Vision Pro headset is displayed at the Fifth Avenue Apple store on Feb. 2, 2024 in New York City.

Michael M. Santiago | Getty Images News | Getty Images

The Vision Pro app gold rush has seen slower uptake than the iPhone’s app boom. 

A year after the iPhone App Store was launched in 2008, Apple was crowing about the platform having 50 million customers, 2 billion downloads and 85,000 apps. Apple regularly told investors and developers how much money it had paid from App Store sales — it hasn’t released any similar stat for the Vision Pro.

Many in the VR industry hoped Apple’s entry would kick off a boom like the iPhone did for mobile apps, creating fortunes as millions of users sought to fill their new devices with fresh software.

“My assumption back then was whatever Apple releases might be in that final form, so it’s a good idea to be ready as early as possible,” said Nikhil Jacob, who runs Vision Uni, which publishes content about developing apps for the Vision Pro. “But my assumption there ended up being wrong.”

Jacob said he believes that an app developer ecosystem for the Vision Pro will take a lot longer to build out than it did for the iPhone because key pieces are missing. Jacob hopes Apple improves the Vision Pro app store to help users find new apps.

The slow uptake, due largely to the high price tag, has led some to worry that VR and its related technologies are once again entering a lull.

“Winter has come,” said Jarrett Webb, who develops headset apps for Argodesign, a software consultancy. “Even Apple couldn’t produce a winner.”

Still, some optimism remains among Vision Pro developers. 

They say that Apple’s hardware is solid, the company’s developer tools are improving, and that the Vision Pro lays the groundwork for future software and hardware updates. It also helps that Vision Pro owners still seem to be excited to try out new apps.

Apple’s entry into the headset market, combined with Google’s recent announcement of its own Android XR platform, as well as Meta’s billions of dollars of investment signals that there will be a market for VR content, said John Gearty, who worked on the Vision Pro at Apple and is the founder of PulseJet Studios, a VR production house focusing on music. Gearty is hoping for steady growth from the market, but he has tempered his expectations. 

“I don’t think it’s ever going to be hockey stick growth,” he said.

Apple has not said if it will update the Vision Pro. According to analysts, the company is working on a successor. Developers want it to be lighter and less expensive. They welcome any improvements that would get it on more faces.

“Over time, everything gets better, and it too will have its course of getting better and better,” Cook told The Wall Street Journal in October. “I think it’s just arguably a success today from an ecosystem-being-built-out point of view.”

— CNBC’s Jonathan Vanian contributed to this report.

Don’t miss these insights from CNBC PRO

Apple has a lot of levers to increase revenue despite tariffs, says Melius' Ben Reitzes

Continue Reading

Technology

Anne Wojcicki has a new offer to take 23andMe private, this time for $74.7 million

Published

on

By

Anne Wojcicki has a new offer to take 23andMe private, this time for .7 million

Anne Wojcicki attends the WSJ Magazine Style & Tech Dinner in Atherton, California, on March 15, 2023.

Kelly Sullivan | Getty Images Entertainment | Getty Images

23andMe CEO Anne Wojcicki and New Mountain Capital have submitted a proposal to take the embattled genetic testing company private, according to a Friday filing with the U.S. Securities and Exchange Commission.

Wojcicki and New Mountain have offered to acquire all of 23andMe’s outstanding shares in cash for $2.53 per share, or an equity value of approximately $74.7 million. The company’s stock closed at $2.42 on Friday with a market cap of about $65 million.

The offer comes after a turbulent year for 23andMe, with the stock losing more than 80% of its value in 2024. In January, the company announced plans to explore strategic alternatives, which could include a sale of the company or its assets, a restructuring or a business combination. 

Read more CNBC tech news

23andMe has a special committee of independent directors in place to evaluate potential paths forward. The company appointed three new independent directors to its board in October after all seven of its previous directors abruptly resigned the prior month. The special committee has to approve Wojcicki and New Mountain’s proposal.

“We believe that our Proposal provides compelling value and immediate liquidity to the Company’s public stockholders,” Wojcicki and Matthew Holt, managing director and president of private equity at New Mountain, wrote in a letter to the special committee on Thursday.

Wojcicki previously submitted a proposal to take the company private for 40 cents per share in July, but it was rejected by the special committee, in part because the members said it lacked committed financing and did not provide a premium to the closing price at the time.

Wojcicki and New Mountain are willing to provide secured debt financing to fund 23andMe’s operations through the transaction’s closing, the filing said. New Mountain is based in New York and has $55 billion of assets under management, according to its website.

23andMe declined to comment.

WATCH: The rise and fall of 23andMe

The rise and fall of 23andMe

Continue Reading

Technology

Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage

Published

on

By

Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage

Hims & Hers

Shares of Hims & Hers Health tumbled more than 23% on Friday after the U.S. Food and Drug Administration announced that the shortage of semaglutide injection products has been resolved.

Semaglutide is the active ingredient in Novo Nordisk‘s blockbuster weight loss drug Wegovy and diabetes treatment Ozempic. Those medications are part of a class of drugs called GLP-1s, and demand for the treatments has exploded in recent years. As a result, digital health companies such as Hims & Hers have been prescribing compounded semaglutide as an alternative for patients who are navigating volatile supply hurdles and insurance obstacles.

Compounded drugs are custom-made alternatives to brand-name drugs designed to meet a specific patient’s needs, and compounders are allowed to produce them when brand-name treatments are in shortage. The FDA doesn’t review the safety and efficacy of compounded products.

Hims & Hers began offering compounded semaglutide to patients in May, and it owns compounding pharmacies that produce the medications.

Compounded medications are typically much cheaper than their branded counterparts. Hims & Hers sells compounded semaglutide for less than $200 per month, while Ozempic and Wegovy both cost around $1,000 per month without insurance.

Read more CNBC tech news

The FDA said Friday that it will start taking action against compounders for violations in the next 60 to 90 days, depending on the type of facility, in order to “avoid unnecessary disruption to patient treatment.”

“Now that the FDA has determined the drug shortage for semaglutide has been resolved, we will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO Andrew Dudum posted Friday on X. “We’re also closely monitoring potential future shortages, as Novo Nordisk stated two weeks ago that it would continue to have ‘capacity limitations’ and ‘expected continued periodic supply constraints and related drug shortage notifications.'”

Him & Hers’ weight loss offerings have been a massive hit with investors. Shares of the company climbed more than 200% last year, and the stock is already up more than 100% this year despite Friday’s move.

Even before it added compounded GLP-1s to its portfolio, the company said in its 2023 fourth-quarter earnings call that it expects its weight loss program to bring in more than $100 million in revenue by the end of 2025.

Despite the turbulent regulatory landscape, Hims & Hers has showed no signs of slowing down.

On Friday, the company announced it has acquired a U.S.-based peptide facility that will “further verticalize the company’s long-term ability to deliver personalized medications.” Hims & Hers will explore advances across metabolic optimization, recovery science, biological resistances, cognitive performance and preventative health through the acquisition, the company said.

That move comes just days after Hims & Hers also bought Trybe Labs, the New Jersey-based at-home lab testing facility. Trybe Labs will allow Hims & Hers to perform at-home blood draws and more comprehensive pretreatment testing.

Hims & Hers did not disclose the terms of either deal.

WATCH: Hims & Hers Super Bowl ad sparks controversy

Hims & Hers Super Bowl ad sparks controversy

Continue Reading

Technology

Tesla recalls more than 375,000 vehicles in U.S. due to failing power-assisted steering systems

Published

on

By

Tesla recalls more than 375,000 vehicles in U.S. due to failing power-assisted steering systems

Tesla models Y and 3 are displayed at a Tesla dealership in Corte Madera, California, on Dec. 20, 2024.

Justin Sullivan | Getty Images

Tesla is voluntarily recalling 376,241vehicles in the U.S. to correct an issue with failing power-assisted steering systems, according to records posted to the website of the U.S. National Highway Traffic Safety Administration.

In a safety recall report posted on the NHTSA website, Tesla said the recall includes Model 3 and Model Y vehicles that were manufactured for sale in the U.S. from Feb. 28, 2023, to October 11, 2023, and that were equipped with a certain older software release.

The records said printed circuit boards in the steering systems in affected vehicles could become overstressed, causing the power-assist steering to fail in some cases when a Tesla vehicle rolled to a stop and then accelerated.

When electronic power-assist steering systems fail in a Tesla, drivers need to exert more force to steer their cars, which can increase the risk of a collision.

Read more CNBC tech news

Tesla told the vehicle safety regulator that it was not aware of any crashes, injuries or deaths related to the power steering failures, and that it was offering an over-the-air software update as a remedy.

The recall follows an earlier related probe and voluntary recall in China concerning the same systems.

President Donald Trump has appointed Tesla CEO Elon Musk to lead a team that is slashing the federal government workforce, and in some cases, regulations and entire agencies. Those cuts already affected the NHTSA, an agency Musk has long seen as standing in the way of some of his ambitions at Tesla.

The regulator has been engaged in a yearslong investigation into safety defects in the systems that Tesla markets currently as its Autopilot and Full Self-Driving (Supervised) options. The features do not make Tesla cars into robotaxis. They require a human driver ready to steer or brake at any time.

The Washington Post reported on Thursday that Musk’s team has led mass firings at the NHTSA, reducing the agency’s workforce and capacity to investigate companies including Tesla by about 10%.

Tesla didn’t respond to a request for comment.

WATCH: Tesla stock hinges on new vehicles being introduced

Tesla stock hinges on new vehicles being introduced, says Canaccord's  George Gianarikas

Continue Reading

Trending